Article
Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors
24 Feb 2020
Abstract excerpt
The androgen receptor (AR) is a critical therapeutic target in prostate cancer that responds to antagonists in primary disease, but inevitably becomes reactivated, signaling onset of the lethal castration-resistant prostate cancer (CRPC) stage. Epigenomic investigation of the chromatin environment and interacting partners required for AR transcriptional activity has uncovered three pioneer factors that open up...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
